| Risk | Moderately Low |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 0.21% |
| NAV | ₹11.34 (29 Oct 2020) |
|---|---|
| Fund Started | 18 Jun 2018 |
| Fund Size | ₹35 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| HDFC Bank Ltd. | Financial | Fixed Deposits | 9.0% |
| Reliance Industries Ltd. | Energy | Equity | 2.6% |
| Biocon Ltd. | Healthcare | Equity | 1.8% |
| Adani Ports and Special Economic Zone Ltd. | Services | Equity | 1.7% |
| Muthoot Finance Ltd. | Financial | Equity | 1.7% |
| Balkrishna Industries Ltd. | Automobile | Equity | 1.7% |
| ICICI Bank Ltd. | Financial | Equity | 1.7% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 1.6% |
| Tata Consumer Products Ltd. | FMCG | Equity | 1.6% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 1.5% |
BOI AXA Arbitrage Fund Direct Growth is a Equity Mutual Fund Scheme launched by BOI AXA Mutual Fund. This scheme was made available to investors on 18 Jun 2018. Ajay Khandelwal is the Current Fund Manager of BOI AXA Arbitrage Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹35 Cr and the Latest NAV as of 29 Oct 2020 is ₹11.34.
The BOI AXA Arbitrage Fund Direct Growth is rated Moderately Low risk. Minimum Lumpsum Investment is 500. Exit load of 0.50% if redeemed within 30 days.
The scheme seeks to generate income through arbitrage opportunities between cash and derivative segments of the equity market and arbitrage opportunities within the derivative segment and by deployment of surplus cash in debt securities and money market instruments.